These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 293457)

  • 1. Relative effectiveness of methods for immunizing BALB/cwm mice to transplantable myelomonocytic leukemia.
    Urnovitz HB; Murphy WH
    Leuk Res; 1979; 3(5):329-39. PubMed ID: 293457
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiation of immunity to murine leukemia (LSTRA) by Bacillus Calmette-Guérin.
    Bartlett GL; Kreider JW; Purnell DM
    Cancer Res; 1978 Dec; 38(12):4401-8. PubMed ID: 719627
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of transplantable myelomonocytic leukemia WEHI-3B in syngeneic BALB/c mice.
    Murphy WH; Urnovitz HB; Maryanski JL; Abrams GD
    Proc Soc Exp Biol Med; 1978 Apr; 157(4):556-64. PubMed ID: 274746
    [No Abstract]   [Full Text] [Related]  

  • 4. F1 hybrid resistance to BN rat myelogenous leukemia parallels resistance to transplantation of normal BN bone marrow.
    Williams RM; Singer DE; Rodday P; Bennett M
    Leuk Res; 1980; 4(2):261-4. PubMed ID: 6997635
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of H-2 restriction in cell-mediated cytotoxicity and transplantation immunity to Leukemia-associated antigens.
    Ting CC; Law LW
    J Immunol; 1977 Apr; 118(4):1259-64. PubMed ID: 191534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal analysis of the action of GM-CSF on the proliferation and differentiation of myelomonocytic leukemic cells.
    Metcalf D
    Int J Cancer; 1979 Nov; 24(5):616-23. PubMed ID: 316807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific immunotherapy with neuraminidase-modified leukemic cells: experimental and clinical trials.
    Bekesi JG; Holland JF; Roboz JP
    Med Clin North Am; 1977 Sep; 61(5):1083-100. PubMed ID: 330972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and humoral immunity to leukemia cells in BCG-induced growth control of a murine leukemia.
    Olsson L; Florentin I; Kiger N; Mathé G
    J Natl Cancer Inst; 1977 Oct; 59(4):1297-306. PubMed ID: 904001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antileukemic effect of systemic non-specific BCG-immunostimulation vs systemic specific immunostimulation with irradiated isogeneic leukemic cells.
    Olsson L; Ebbesen P; Kiger N; Florentin I; Mathé G
    Eur J Cancer (1965); 1978 Apr; 14(4):355-62. PubMed ID: 348478
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c mice.
    Parmiani G; Sensi ML; Carbone G; Colombo M; Pierotti M; Ballinari D; Hilgers J; Hilkens J
    Int J Cancer; 1982 Mar; 29(3):323-32. PubMed ID: 7068280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The origin and role of blood-borne monocytes in rats with a transplanted myelogenous leukaemia.
    Gauci CL; Wrathmell A; Alexander P
    Cancer Lett; 1975 Sep; 1(1):33-7. PubMed ID: 797440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum protein changes in the development of a transplantable murine ascites myeloid leukemia.
    Merino F
    Oncology; 1974; 29(4):283-93. PubMed ID: 4526322
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of transplantation immunity by dansylated tumor cells.
    Hashimoto Y; Yamanoha B
    Gan; 1976 Apr; 67(2):315-9. PubMed ID: 964559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia of BALB/c mice induced by cellfree filtrate from transplantable Thurzo--Svec rat leukemia.
    Verhatzky PP; Gluzman DF
    Neoplasma; 1976; 23(3):271-6. PubMed ID: 1066527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility and resistance to viral leukemogenesis in the mouse. IV. Mechanisms of host resistance to leukemia expression.
    Tennant JR
    J Natl Cancer Inst; 1972 Nov; 49(5):1257-67. PubMed ID: 4346533
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune response to weakly immunogenic virally induced tumors. IV. Dissociated recognition of H-2 and tumor-associated antigens.
    Devens B; Naor D; Kedar E
    Transplantation; 1979 Nov; 28(5):389-95. PubMed ID: 160637
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiation-induced myeloid leukaemia in CBA/H mice: a non-immunogenic malignant disease in syngeneic mice.
    Meldrum RA; Mole RH
    Br J Cancer; 1982 Mar; 45(3):403-12. PubMed ID: 7041940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cell-mediated immunity against leukemia EL4 in C57BL mice.
    Kemp A; Berke G; Crowell J; Amos B
    J Natl Cancer Inst; 1973 Dec; 51(6):1877-82. PubMed ID: 4765391
    [No Abstract]   [Full Text] [Related]  

  • 19. [Histocompatibility antigens of 2 transplantable reticulum cell tumors TRH 3 and TRBL 3 (induced in BALB/c/Cb/Se and C57BL/Cb/Se mice with ascites mammary carcinoma ATPC+). I. Transplantability tests].
    Maltzeff N
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1975; 35(1):29-41. PubMed ID: 1243772
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenic properties of solubilized tumour antigen from an RNA virus-transformed neoplasm.
    Law LW; Apella E
    Nature; 1973 May; 243(5402):83-7. PubMed ID: 4122415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.